Texas Attorney General Ken Paxton has filed a motion to block pharmaceutical company Kenvue—the manufacturer of Tylenol—from issuing a scheduled dividend payment later this month. The move comes as the state pursues a high-profile lawsuit against Kenvue and its former parent company, Johnson & Johnson, alleging deceptive marketing practices tied to the use of Tylenol during pregnancy. The dividend, set for distribution on November 26, has become the latest f